Literature DB >> 33029620

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Chanu Rhee1,2,3, Sanjat Kanjilal1,2, Meghan Baker1,2,3, Michael Klompas1,2,3.   

Abstract

Defining the duration of infectivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has major implications for public health and infection control practice in healthcare facilities. Early in the pandemic, most hospitals required 2 negative RT-PCR tests before discontinuing isolation in patients with Covid-19. Many patients, however, have persistently positive RT-PCR tests for weeks to months following clinical recovery, and multiple studies now indicate that these generally do not reflect replication-competent virus. SARS-CoV-2 appears to be most contagious around the time of symptom onset, and infectivity rapidly decreases thereafter to near-zero after about 10 days in mild-moderately ill patients and 15 days in severely-critically ill and immunocompromised patients. The longest interval associated with replication-competent virus thus far is 20 days from symptom onset. This review summarizes evidence-to-date on the duration of infectivity of SARS-CoV-2, and how this has informed evolving public health recommendations on when it is safe to discontinue isolation precautions.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; isolation; transmission-based precautions

Year:  2021        PMID: 33029620      PMCID: PMC7499497          DOI: 10.1093/cid/ciaa1249

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  65 in total

1.  Evaluation of the Roche antigen rapid test and a cell culture-based assay compared to rRT- PCR for the detection of SARS-CoV-2: A contribution to the discussion about SARS-CoV-2 diagnostic tests and contagiousness.

Authors:  Jacqueline Steinlin-Schopfer; Maria Teresa Barbani; Richard Kamgang; Martina Zwahlen; Franziska Suter-Riniker; Ronald Dijkman
Journal:  J Clin Virol Plus       Date:  2021-05-09

Review 2.  COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.

Authors:  Kevin Escandón; Angela L Rasmussen; Isaac I Bogoch; Eleanor J Murray; Karina Escandón; Saskia V Popescu; Jason Kindrachuk
Journal:  BMC Infect Dis       Date:  2021-07-27       Impact factor: 3.090

3.  "Long COVID": A case report of persistent symptoms in a patient with prolonged SARS-CoV-2 shedding for over 110 days.

Authors:  Ayanfe Omololu; Barakah Ojelade; Oluwatomiwa Ajayi; Tolu Adesomi; Oreoluwa Alade; Segun Adebisi; Victor Nwadike
Journal:  SAGE Open Med Case Rep       Date:  2021-05-16

4.  Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study.

Authors:  SeyedAhmad SeyedAlinaghi; Ladan Abbasian; Mohammad Solduzian; Niloofar Ayoobi Yazdi; Fatemeh Jafari; Alireza Adibimehr; Aazam Farahani; Arezoo Salami Khaneshan; Parvaneh Ebrahimi Alavijeh; Zahra Jahani; Elnaz Karimian; Zahra Ahmadinejad; Hossein Khalili; Arash Seifi; Fereshteh Ghiasvand; Sara Ghaderkhani; Mehrnaz Rasoolinejad
Journal:  Eur J Med Res       Date:  2021-05-06       Impact factor: 2.175

5.  Quantifying the Impact of Nasopharyngeal Specimen Quality on Severe Acute Respiratory Syndrome Coronavirus 2 Test Performance.

Authors:  Melissa Richard-Greenblatt; Matthew J Ziegler; Valerie Bromberg; Elizabeth Huang; Hatem Abdallah; Pam Tolomeo; Ebbing Lautenbach; Laurel Glaser; Brendan J Kelly
Journal:  Open Forum Infect Dis       Date:  2021-05-12       Impact factor: 4.423

6.  Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling.

Authors:  Satoshi Irifune; Nobuyuki Ashizawa; Takahiro Takazono; Pierre Mutantu; Takeshi Nabeshima; Mya Myat Ngwe Tun; Kenji Ota; Tatsuro Hirayama; Ayumi Fujita; Masato Tashiro; Takeshi Tanaka; Kazuko Yamamoto; Yoshifumi Imamura; Taiga Miyazaki; Toyomitsu Sawai; Koichi Izumikawa; Katsunori Yanagihara; Kouichi Morita; Hiroshi Mukae
Journal:  J Infect Chemother       Date:  2021-07-16       Impact factor: 2.211

Review 7.  Time to 'Mind the Gap' in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2.

Authors:  Colleen B Jonsson; Jennifer E Golden; Bernd Meibohm
Journal:  Curr Opin Virol       Date:  2021-06-29       Impact factor: 7.090

Review 8.  COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures.

Authors:  Robert Rosolanka; Andres F Henao-Martinez; Larissa Pisney; Carlos Franco-Paredes; Martin Krsak
Journal:  Ther Adv Infect Dis       Date:  2021-07-14

9.  Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.

Authors:  Antonin Bal; Karen Brengel-Pesce; Alexandre Gaymard; Grégory Quéromès; Nicolas Guibert; Emile Frobert; Maude Bouscambert; Mary-Anne Trabaud; Florence Allantaz-Frager; Guy Oriol; Valérie Cheynet; Constance d'Aubarede; Amélie Massardier-Pilonchery; Marlyse Buisson; Julien Lupo; Bruno Pozzetto; Pascal Poignard; Bruno Lina; Jean-Baptiste Fassier; Florence Morfin; Sophie Trouillet-Assant
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

10.  Duration of SARS-CoV-2 shedding: A population-based, Canadian study.

Authors:  Susan P Phillips; Xuejiao Wei; Jeffrey C Kwong; Jonathan Gubbay; Kevin L Schwartz; Anna Majury; Patti A Groome
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.